XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.34

-2.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (17166)	7/16/2005 12:35:26 PM
From: Edscharp	of 17367

Is news tonight the final stake or silver bullet to put this one out of it's misery? Tex, Final stake? No way!! From Xoma's conniving point of view this is another opportunity to repackage the hopes and dreams of a BPI platform that can potentially cure....well everything! Why'd Xoma start with Zephyr Biosciences anyway? Zephyr wasn't a biotech company and never was. Zephyr is a venture capital company and a new one at that. They have no experience, reputation or credibility in the biotech world. How tough is it for a venture capital company with no reputation or money to acquire the tens of millions of dollars which they would've needed for their salaries, the $11M payment to Xoma, and the P2 & P3 trials? Pretty dang tough I'd say. In fact, they couldn't do it. Nope, hope springs eternal. As long as Xoma has a firm grip on the BPI platform there is always the hope they will find some sucker to fund trials. You wait and see. There is one born every minute. P.T. Barnum said so and you'd do well to listen to him.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next